Honolulu, May 2026 — The Hawaii Comprehensive Epilepsy Center & Epilepsy Research Unit has been awarded the FOCUS 2 study investigating RAP-219, an investigational modulator of AMPA receptors, for adult patients with focal seizures. RAP-219 is a first-in-class, selective negative…
Honolulu, June 2026 — The Hawaii Comprehensive Epilepsy Center & Epilepsy Research Unit has been awarded a study investigating JZP926 or Epidiolex for the treatment of Juvenile Myoclonic Epilepsy (JME). JME is the most common generalized epilepsy syndrome. Myoclonic jerks…
The team at Hawaii Comprehensive Epilepsy Center & Epilepsy Research Unit. Honolulu, June 2026 — The Hawaii Comprehensive Epilepsy Center & Epilepsy Research Unit has been awarded a study investigating BMB-101 for the treatment of Developmental and Epileptic Encephalopathies (DEEs).…
To encourage neurologists to give back to students and support our medical community, Hawaii neurologists are invited to attend and serve on the Panel of Judges for the 2027 Hawaii Neuroscience Symposium Student Poster Competition on Saturday, August 1, 2026,…
RECENT BLOGS
-
RAP-219 FOCUS 2 Focal Seizure Study | Hawaii Epilepsy
-
JZP926 & Epidiolex JME Study | Hawaii Epilepsy Center
-
BMB-101 Epilepsy Study (DEEs) | Hawaii Epilepsy Research
-
Hawaii Neurologists: Give Back to Students & Get a Free 2027 HNS Membership Renewal
-
Dr. Natalia Gonzalez Caldito Named Chief of Staff at Hawaiʻi Pacific Neuroscience
-
Hawaii Pacific Neuroscience Physicians Named 2026 Castle Connolly Top Doctors
-
Dr. Kore Kai Liow Named 2026 Hawaii Physician of the Year | HPN
-
University of Hawaii Professor & Researcher Publishes Buntanetap Study in Nature — A Novel Oral Therapy Targeting APP and Tau in Alzheimer’s Disease
HPN Office Hours
Monday :
8AM - 5PM
Tuesday :
8AM - 5PM
Wednesday :
8AM - 5PM
Thursday :
8AM - 5PM
Friday :
8AM - 5PM
Saturday :
CLOSED
SUNDAY :
CLOSED